These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20716873)

  • 1. [Impact of HER2, EGFR, IGF-1R, and VEGFR expressions on the outcome of chemotherapy for advanced gastric cancer].
    Matsubara J; Hirashima Y; Yamada Y
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1489-96. PubMed ID: 20716873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
    Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer.
    Matsubara J; Yamada Y; Nakajima TE; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Oncology; 2008; 74(1-2):76-83. PubMed ID: 18544998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor (EGFR), HER2 and insulin-like growth factor-1 receptor (IGF-1R) status in ovarian adult granulosa cell tumours.
    Higgins PA; Brady A; Dobbs SP; Salto-Tellez M; Maxwell P; McCluggage WG
    Histopathology; 2014 Apr; 64(5):633-8. PubMed ID: 24206174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.
    Hirashima Y; Yamada Y; Matsubara J; Takahari D; Okita N; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Cancer Sci; 2009 Feb; 100(2):310-5. PubMed ID: 19068081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
    Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
    Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
    Valsecchi ME; McDonald M; Brody JR; Hyslop T; Freydin B; Yeo CJ; Solomides C; Peiper SC; Witkiewicz AK
    Cancer; 2012 Jul; 118(14):3484-93. PubMed ID: 22086503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
    Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
    Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of PTEN, EGFR, HER-2, and IGF-1R in gastric cancer patients treated with postoperative chemoradiation.
    Benli Yavuz B; Koç M; Kozacıoğlu S; Kanyılmaz G; Aktan M
    Turk J Med Sci; 2019 Aug; 49(4):1025-1032. PubMed ID: 31318186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas.
    Asmane I; Watkin E; Alberti L; Duc A; Marec-Berard P; Ray-Coquard I; Cassier P; Decouvelaere AV; Ranchère D; Kurtz JE; Bergerat JP; Blay JY
    Eur J Cancer; 2012 Nov; 48(16):3027-35. PubMed ID: 22682017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
    Terashima M; Kitada K; Ochiai A; Ichikawa W; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M;
    Clin Cancer Res; 2012 Nov; 18(21):5992-6000. PubMed ID: 22977193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer.
    Ge J; Chen Z; Wu S; Chen J; Li X; Li J; Yin J; Chen Z
    Digestion; 2009; 80(3):148-58. PubMed ID: 19713703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
    Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
    Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.
    Takahari D; Yamada Y; Okita NT; Honda T; Hirashima Y; Matsubara J; Takashima A; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Oncology; 2009; 76(1):42-8. PubMed ID: 19033715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
    Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
    Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
    Xia M; Overman MJ; Rashid A; Chatterjee D; Wang H; Katz MH; Fleming JB; Lee JE; Varadhachary GR; Wolff RA; Wang H
    Hum Pathol; 2015 Sep; 46(9):1315-22. PubMed ID: 26165226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
    Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
    Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.